Wednesday March 10, 2010
at HomeTownAccess.Net

Welcome!

Home

Expanding Internet Services

HomeTownAccess is a premier low cost Internet service provider. We offer reliable dial-up Internet access to customers in NE Arkansas, SE Missouri, and Western Tennessee. With our dial-up Internet service there is no software required. You can use our dial-up Internet service on all operating systems such as Windows, Macintosh or Linux. Sign up today and start saving money by using us as your dial-up Internet provider. If you have any questions regarding our dial-up Internet service please feel free to contact us.

Web Directory

Our Services:

Internet Image

Our Unlimited Dial-Up Internet Access Plan is our most popular plan for Internet Access. For $14.95 per month you get unlimited dial-up Internet Access with 10 E-mail Accounts & 100MB of personal web storage space. This plan also includes webmail access, spam and virus filtering for your e-mail and popup blocking and anti-virus software for your computer.

Limited Image

Our Limited Dial-Up Internet Access Plan is a good choice for people who do not require more than 10 hours of Internet Access per month. This solution is ideal for a traveling user, or one who has a broadband connection and needs an inexpensive Internet access backup solution. This plan includes all of the features of our Unlimited Dial-Up plan, for only $9.95/month.

Email Image

Our E-mail Only Plan is perfect for people who have another sort of internet access, but require a stable, dependable, robust, and secure e-mail account. Unlike the "free" e-mail providers, there are no expiry dates or time limits on your account; your e-mail will ALWAYS be there. This plan costs $4.95/month and includes 1 e-mail address and 100 MB of disk space. You also get webmail access and spam and virus filtering.

Current Weather:

Local News:

Helix BioPharma Corp. Announces Fiscal Q2 2010 Results
Extract not available.
More... - Wed, 10 Mar 2010 08:13:00 GMT

Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously
More... - Wed, 10 Mar 2010 07:34:00 GMT

Black & Decker Issues Further Statement in Connection with the Special Meetings of Stockholders to Consider the Stanley Transaction
The Black & Decker Corporation (NYSE: BDK) issued a press release in which it stated, in part, that "Personal business relationships between individuals (as opposed to relationships with the company) generally are not relevant to the independence tests
More... - Wed, 10 Mar 2010 07:33:00 GMT